MissionIR Small-Cap Investor Blog: January 2022

Monday, January 31, 2022

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partners with Industrial Automation Leader for Full-Scale Automotive Body Assembly

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced that it will be working with Italy-based Comau, a leading systems integrator and solutions provider in the automotive sector, in building the vehicle body shop at MULN’s Advanced Manufacturing and Engineering Center (“AMEC”) in Tunica, Mississippi. Collaborating with Comau will allow Mullen to build a state-of-the-art body shop for its new Mullen FIVE EV Crossover. According to the announcement, Comau has been a leader in automotive manufacturing for more than 40 years and has established a reputation for combining innovative engineering solutions with easy-to-use open automation and enabling technologies. The strategic partnering of the two companies is designed to produce the most accurate and quality body shops, which will ensure the high quality expected of the FIVE. As it designs the processes and equipment for the AMEC facility, Comau is actively supporting Mullen’s plans for its vehicles. “Comau is an international leader in developing world-class automation technology and vehicle body shops for the automotive industry,” said Mullen Automotive CEO and chairman David Michery in the press release. “We are excited to have them working on developing our body shop plan for Tunica AMEC.”

To view the full press release, visit https://ibn.fm/bCANs

About Mullen Automotive Inc.

Mullen is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership. To learn more about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) (FSE: 80W) Secures Approval to Sell Products in Peru

Save Foods (NASDAQ: SVFD) (FSE: 80W), an agri-food tech company specializing in eco crop protection, today announced its receipt of approval from the Ministry of Agricultural Development and Irrigation to sell its products in Peru. Ranking among the world’s top ten fruit-exporting countries, Peru’s export of fresh fruit and vegetables has grown rapidly in recent years, reaching $3.8 billion in 2020. “Save Foods’ treatment helps packing houses to address the growing challenges of exporting fruit and vegetables while maintaining their freshness and reducing waste after an extended export process. Peruvian exporters face this challenge on a daily basis as it can take between three to five weeks to deliver Peruvian produce to the average European retailer,” said Dan Sztybel, CEO of Save Foods Ltd., the company’s Israeli subsidiary. “Our treatment fights pathogens, which are largely responsible for decay, and can be used in combination with, or as a replacement for, pesticides that leave chemical residues on fresh produce. This helps packers meet the requirements of the EU’s recently established ‘Farm to Fork Green Deal Initiative’ while maintaining high-quality produce.”

To view the full press release, visit https://ibn.fm/ur5kD

About Save Foods Inc.

Save Foods is an Israel-based agri-food tech company that addresses two of the most significant challenges in the fresh produce industry: food waste and loss and food safety. Save Foods is dedicated to delivering cost-effective, easy to implement solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops technology that benefits the entire supply chain and improves the safety and quality of life of both workers and consumers. Save Foods’ initial applications are in post-harvest treatments in fruit and vegetable packing houses processing citrus, avocado, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods’ eco products not only prolong the shelf life of fresh produce and reduce food loss and waste, but they also ensure a safe-to-consume end product. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About MissionIRNewsBreaks

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

FingerMotion Inc. (NASDAQ: FNGR) Marks a 21% Year-Over-Year Growth in Revenue for Q3 2022; Anticipates Significant Growth in the Next Fiscal year

FingerMotion attributed its strong finish for Q3 2022 to strategic investments and collaborations with key players in the industry
It hopes to carry on this performance trend into the next fiscal year, tapping into the investments and collaborations made so far
The company also plans to capitalize on the insurtech sector while also forming new brands designed to offer mobile device protection for the Chinese market

FingerMotion (NASDAQ: FNGR), recently released its financial results for the third quarter of the 2022 financial year (“Q3 2021”), posting a 21% growth in revenue from the same period in 2020. Martin Shen, the Chief Executive officer (“CEO”) of the company, termed this a “strong finish” while also expressing his optimism for even better performance in the next fiscal year (https://ibn.fm/iWS7u).

This growth for Q3 2022 was attributed to the company’s strategic investments and collaborations with key players in the industry, most notably China Mobile in the Fujian province.

“The third quarter finished strong with $5.9 million in revenue and an acceleration of our top-up business,” Mr. Shen noted. “During the quarter, we were aggressive in rolling out our collaboration with China Mobile in Fujian province,” he added.

Gross profit for Q3 2022 stood at $967,075, representing a 56% year-over-year growth from the same period the previous year. In addition, its Telecommunications Products and Services business posted total revenue of $2.8 million, a 580% year-over-year quarterly growth from the same period in 2020.

FingerMotion closed the 2021 calendar year with significant investment into its insurtech sector. Its services agreement with Pacific Life Re, through its big data analytic division, Sapientus, coupled with its collaboration with Xuanlian Tianxia Technology and Happy Life Insurance, make it a formidable force in the Insurtech space. Mr. Shen is confident that in the new year, revenue should ramp up as the insurtech business starts to unfold, all while tapping into the big data in the insurance market that is projected to be valued at $12 billion by 2023 (https://ibn.fm/dE4dz).

The company has also formed new brands designed to offer mobile device protection in China, with Beta testing already underway. Mr. Shen is optimistic that this investment will represent a significant revenue stream in the next fiscal year, even as it works on other aspects of its operations, including creating new insurance products.

“Our teams are uniquely qualified to create new insurance products that push the envelope of what is possible. Our goal is to enable the creation and distribution of insurance solutions that match consumer profiles, offer more flexibility and ultimately cost savings to the consumer while at the same time creating underwriting efficiencies that will eventually drop down to the bottom line, making our collaboration particularly rewarding in the long run,” noted Mr. Shen.

In January 2022, FingerMotion became the latest technology company listed on the Nasdaq Capital Market in a move that offered it great exposure within the investment community. Mr. Shen believes that this, coupled with the investments made over the 2021 calendar year, will continue to strengthen the company’s balance sheet and profitability, carrying on the trend posted in Q3 2022.

For more information, visit the company’s website at www.FingerMotion.com.

NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) IRB-Approved Study Could ‘Lead to New Frontiers,’ Begins Enrollment This Year

Upcoming study supports CYBN’s mission to develop psychedelics into therapeutics.
Kernel Flow uses pulsed light instead of continuous wave light to increase measured brain information.
Study may provide crucial “mind-imaging” information that has been previously missing.

Cybin (NEO: CYBN) (NYSE American: CYBN) is starting off the new year right — the company has received approval from an Institutional Review Board (“IRB”) for a feasibility study using Kernel’s quantitative neuroimaging technology, Kernel Flow. Enrollment for the study begins early this year (https://ibn.fm/XTXAe).

“By leveraging the Kernel Flow technology, we may have the ability to measure longitudinal brain activity before, during and after a psychedelic experience, and collect quantitative data as opposed to subjective patient reporting,” said Cybin CEO Doug Drysdale. “We believe the results of this study will lead to future studies that will test the effectiveness of psychedelic treatments and will further support our mission to develop psychedelics into therapeutics.”

The feasibility study is designed to utilize Kernel’s Flow technology to evaluate ketamine’s psychedelic effect on cerebral cortex hemodynamics (https://ibn.fm/YeDwV). This study could provide crucial information that “may lead to new frontiers in psychedelic therapeutics by enabling the acquisition of longitudinal brain activity before, during and after a psychedelic experience, providing quantification of what was previously subjective patient reporting,” the company noted.

“The word psychedelic means ‘mind-manifesting,’ but what has been missing is useful ‘mind-imaging’—the ability to dynamically trace the neural correlates of human conscious experience,” explained Cybin’s chief clinical officer, Dr. Alex Belser. “Conventional neuroimaging just isn’t dynamic enough to study the psychedelic experience in the brain as it happens. This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding.”

Kernel’s exclusive tech, called Kernel Flow, uses pulsed light instead of continuous wave light to increase measured brain information. The device used to measure the information is easily wearable, which is a significant difference from electroencephalography (“EEG”) electrodes that typically require gel on the head or functional magnetic resonance imaging (“fMRI”) studies that require a participant to lie in a scanner. The entire system is the size and look of a bicycle helmet and could, in the future, be more broadly used for neuroscientific or physiological studies of brain activity during psychedelic use, noted Cybin.

“Quantitatively measuring the brain within the context of a psychedelic experience is a promising frontier,” said Kernel founder and CEO Bryan Johnson. “With Kernel Flow, Cybin’s researchers can start putting numbers and quantification to subjective states of mind, including altered ones.”

As a sponsor of the study, Cybin retains an exclusive interest in any innovations that are discovered or developed through its independent analysis of the study findings. Kernel will hold the same rights relating to its Kernel technology.

“We hope this feasibility study can bridge the gap of real-time quantitative data collection during psychedelic treatments to further understand the correlation of effects from these powerful molecules,” said Drysdale. “The ability to access real-time brain activity data during a psychedelic experience has tremendous potential for the development of future psychedelic therapeutics.”

Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom and Ireland. The company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About MissionIR

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX), Convertible Note Investor Collaborate to Mitigate Immediate Conversion Risk

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, today announced that it has entered into an agreement with respect to the $100 million convertible note financing, originally entered into on Nov. 2, 2021, in order to relieve immediate conversion concerns. Under the agreement, as detailed on GreenBox’s simultaneously filed Form 8-K, certain conversion triggers will be extended from February 3 to May 2, 2022. The 90-day extension offers the company the time to push its business forward toward increased growth, leading to a potentially higher valued stock price and, perhaps, even driving it to a level where the note may be cleared altogether. In a mutually beneficial arrangement, GreenBox has agreed to reduce the note principal to $94,000,000 from the original $100,000,000 in consideration of a payment of $6.9 million. “While raising capital to further fuel our growth initiatives is essential, ensuring long-term value for our esteemed shareholder community is critical. As we take this step with the full cooperation of the investor holding this note, we are delighted to have successfully renegotiated these amended terms,” said Ben Errez, chairman of GreenBox POS. “With a robust pipeline of transformative upcoming initiatives, we are incredibly confident in our ability to execute on our corporate objectives and further deliver the results our shareholders expect from our organization.”

To view the full press release, visit https://ibn.fm/7ZBCe

About GreenBox POS

GreenBox is an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions. The company’s applications enable an end-to-end suite of turnkey financial products, helping to reduce fraud and improve the efficiency of handling large-scale commercial processing volumes for its merchant clients globally. For more information, please visit the company’s website at www.GreenBoxPOS.com.

NOTE TO INVESTORS: The latest news and updates relating to GBOX are available in the company’s newsroom at https://ibn.fm/GBOX

About MissionIRNewsBreaks

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Offers a Glimpse into Company’s Unique Technology and Operations on EDGE Podcast

Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. White
He provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technology
Mr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment

Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ: LEXX), was recently featured on episode 234 of the EDGE Podcast. Hosted by Brandon C. White, an Angel Investor and Entrepreneur, Mr. Bunka shared insights into his professional journey while also sharing what the company is committed to achieving going forward.

Mr. Bunka lauded the company’s patented DehydraTECH(TM) technology, citing how integral it is to improve the delivery of active pharmaceutical ingredients and other fat-soluble molecules. So far, this technology has proven promising for the potential treatment of hypertension and heart disease, and is already being sublicensed for the delivery of CBD.

“Our technology is all about enabling a much higher fraction and a much smoother delivery of the beneficial substances in the foods you eat and in the drugs you take and, quite frankly, getting them into your bloodstream,” he noted (https://ibn.fm/kGRDm).

He also walked the audience through his career growth that spans over four decades, having started his first business at the age of 17. Over the years, he notes, he has learned how to run a business, rely on other people, and manage employees, skills that have translated to the success of Lexaria thus far.

When asked about his most significant career lessons, Mr. Bunka reckoned that while he has learned a lot, the central aspect is the significance of understanding the competitive environment. He further advised small companies and entrepreneurs first to understand their competitive environment and then understand the products and services they offer to customers.

“A lot of small companies don’t do a good job of understanding their competitive environment,” he noted. “A lot of them say, ‘I’m the best, I’m the fastest.’…I could be on my laptop and have somebody pitching me on an idea, and I see 3,700 companies just like his. It makes it really hard, so understanding your competitive environment is really, really important, as well as understanding your products and services,” he added.

The interview with Mr. Bunka offered a glimpse into the inner workings of Lexaria, the vision that he has for the company, and the goals that it is working towards. In addition, he talked about the company’s ongoing efforts to make the most out of its innovative delivery platform, along with professional philosophies that have guided his career so far.

You can listen to the entire interview here https://ibn.fm/3QMBD

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About MissionIR

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

MissionIRNewsBreaks — Growth Capital Acquisition Corp. (NASDAQ: GCAC) Shares Update on Registration Statement, Special Meeting

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a special purpose acquisition company, announced that the Securities and Exchange Commission (“SEC”) declared effective the company’s recent Form S-4 registration statement, which includes a definitive proxy statement in connection with a special meeting of GCAC’s stockholders. The meeting is slated for Feb 9, 2022, at 10 a.m. ET. According to the announcement, Growth Capital’s stockholders plan to consider the company’s proposed business combination with Cepton Technologies Inc. at the upcoming meeting. Cepton is a developer of lidar-based solutions for automotive, smart cities, smart spaces and smart industrial applications. The company also indicated that, once the business transaction is closed, it anticipates that the combined company’s common stock and warrants will be listed on Nasdaq under the ticker symbols CPTN and CPTNW. According to the company, GCAC stockholders of record on Jan. 13, 2022, are eligible to vote during the meeting; registration instructions along with definitive proxy statement and other relevant documents were mailed to stockholders of record last week.

To view the full press release, visit https://ibn.fm/sIO1g

About Growth Capital Acquisition Corp.

GCAC is a Delaware blank check company, also commonly referred to as a special purpose acquisition company (“SPAC”), formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities in any industry or geographic region. GCAC is led by its co-CEOs Akis Tsirigakis and George Syllantavos. For more information about the company, visit www.GCACorp.com.

NOTE TO INVESTORS: The latest news and updates relating to GCAC are available in the company’s newsroom at https://ibn.fm/GCAC

About MissionIRNewsBreaks

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com